Literature DB >> 12508715

Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").

T Miyata1.   

Abstract

Aging is accompanied by a progressive and irreversible non-enzymatic modification of protein by carbohydrates, eventually yielding the advanced glycation end products (AGEs). Age generation (Maillard reaction) is markedly augmented in diabetes with sustained hyperglycemia but also in normoglycemic uremia and atherosclerosis. Recent studies have brought new insights into broad derangements in non-enzymatic biochemistry involving not only carbohydrates but also lipids, present in diabetes, uremia, and atherosclerosis. The latter have in common increased levels of reactive carbonyl compounds (RCOs) with attendant protein modifications ("carbonyl stress"). Carbonyl stress might be derived from 1) hyperglycemia (lipemia), 2) oxidative stress, and/or 3) impaired detoxification of RCOs. Manipulation of carbonyl stress in diabetes, uremia and atherosclerosis opens new therapeutic approaches including redox modulation, RCO detoxification, and carbonyl stress inhibition. The first generation of carbonyl stress inhibitors such as aminoguanidine trap RCOs with its hydrazine group. Unfortunately, aminoguanidine (AG) traps pyridoxal as well as noxious RCOs, so that its long-term administration in animals results in vitamin B6 deficiency and neurotoxicity. Fortunately, newer compounds devoid of such side effects, have opened exciting prospects. Widely used hypotensive agents, such as angiotensin converting enzyme (ACE) inhibitor and angiotensin II receptor antagonist, but not calcium blockers, prove more effective than AG in attenuating the production of AGEs. Unlike AG, they do not act as RCO trapping agents, but impact upon the production of RCO precursors by scavenging a variety of radicals and altering oxidative stress, a mechanism similar to that involved in the inhibitory action of nitric oxide on AGE formation. These results provide a new framework to assess families of compounds according to their mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12508715

Source DB:  PubMed          Journal:  Bull Mem Acad R Med Belg        ISSN: 0377-8231


  4 in total

1.  Oxidative protein damage is associated with elevated serum interleukin-6 levels among older moderately to severely disabled women living in the community.

Authors:  Margaret Dayhoff-Brannigan; Luigi Ferrucci; Kai Sun; Linda P Fried; Jeremy Walston; Ravi Varadhan; Jack M Guralnik; Richard D Semba
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-02       Impact factor: 6.053

2.  Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report.

Authors:  Y H M Krul-Poel; R Agca; P Lips; H van Wijland; F Stam; S Simsek
Journal:  Cardiovasc Diabetol       Date:  2015-07-16       Impact factor: 9.951

3.  The Relationship Between Hemoglobin Glycation Variation Index and Vitamin D in Type 2 Diabetes Mellitus.

Authors:  Zelin Li; Fei Wang; Yujiao Jia; Feiyue Guo; Shuchun Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-30       Impact factor: 3.168

Review 4.  Beneficial Effect of 7-O-Galloyl-D-sedoheptulose, a Polyphenol Isolated from Corni Fructus, against Diabetes-Induced Alterations in Kidney and Adipose Tissue of Type 2 Diabetic db/db Mice.

Authors:  Chan Hum Park; Jeong Sook Noh; Jong Cheol Park; Takako Yokozawa
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-20       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.